Medical Device | March 07, 2022
Thermo Fisher Scientific unveils new genetic analyzer
Expanding the Applied Biosystems portfolio with the latest generation of innovative, mid-throughput genetic analyzers
Expanding the Applied Biosystems portfolio with the latest generation of innovative, mid-throughput genetic analyzers
Covaxin is not approved in the USA for any age group
The company also reported the issuance of an additional U.S. patent covering the drug, and the filing of a continuation patent application intended to expand patent coverage to other facets of the drug
Collaboration aims to capture patient-to-patient variability to determine the best treatment for every cancer
It plans launch various other health monitoring tools for smartphones, making existing devices obsolete
Meteoric Biopharmaceuticals have made rapid strides in the development of enzymes, probiotics and veterinary health products. It is seeking opportunities to scale up its growth backed by cutting edge R&D. Gaurav Kaushik, MD & CEO, Meteoric Biopharmaceuticals spoke to Thomas C Thottathil on the way forward
Novel delivery of established growth and neurotrophic factors enables local, sustained release for greater efficacy
TruPharma has commenced commercial marketing of Sage's approved generic cartridge product
This has further strengthened its manufacturing presence in the United States of America
Innovative TIMScore for dda-PASEF and dia-PASEF libraries, combined with TIMS DIA-NN identifies 9000 protein groups from 200 ng K562 lysate in just 35 min gradient
Subscribe To Our Newsletter & Stay Updated
